Navigation Links
Study finds that practice makes perfect in lung cancer surgery
Date:10/23/2008

DURHAM, N.C. -- Patients operated on by surgeons who do not routinely remove cancer from the lungs may be at a higher risk for complications, according to a study conducted by researchers at Duke University Medical Center.

"Our study found that hospitals that do higher volumes of these types of surgeries have correspondingly lower mortality rates than those who do fewer of the procedures," said Andrew Shaw, M.D., an anesthesiologist at Duke and lead investigator on the study.

"This has important implications for both patients and doctors: patients should choose a center that does these procedures often, and doctors who are only doing a few of these a year should consider either growing their practices, or focusing their attention on other, less complex, types of surgery."

The results of the study will be published in the December issue of the journal Cancer Therapy, but they have already appeared online on the journal's Web site. The study was funded by Duke's department of anesthesiology.

The researchers used the Nationwide Inpatient Sample, a publicly-available database of hospital admissions dating back 20 years and representing approximately 90 percent of hospitals in the country, to examine death rates following three common types of surgery for lung cancer -- pneumonectomy, in which the whole lung is removed, lobectomy, in which a third to half of the lung is removed, and segmental resection, in which a smaller portion of the lung is removed. Over 130,000 patient data samples were studied.

"Mortality is highest, for all three procedures, at institutions which perform very few of these types of operations," Shaw said. "Hospitals that perform 40 procedures or more per year have the lowest mortality rates."

The study also found that mortality in teaching hospitals is slightly lower than in non-teaching institutions.

"Patients are sometimes wary of having their surgery performed at a teach
'/>"/>

Contact: Lauren Shaftel Williams
lauren.shaftel@duke.edu
919-684-4966
Duke University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New National Medicaid Study Underscores Importance of Including State Relief in Stimulus Plan
2. Study shows steroid therapies following transplant can be eliminated
3. Booz & Company Study Finds Top Corporate Spenders on R&D Boosted Investments to Nearly Half a Trillion Dollars in 2007
4. New CHARISMA Outcome Study Results Validate Aspirin Effect
5. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study
6. DecisionView Unveils the Next Generation of Clinical Trial Software: StudyOptimizer 4.0
7. Hooper Holmes Heritage Labs Division to Manufacture Biospecimen Kits for the National Childrens Study
8. Stuart Chesky, DO, JD, Ohio KePRO Medical Director, Appointed to Ohio Joint Legislative Study Commission on Most Favored Nation Clauses in Health Care Contracts
9. Study Evaluates Laser Therapies for Hair Removal
10. New Study Reveals Consumers Want Greater Say in Key Food Issues
11. American Association for the Study of Liver Diseases Enters Into Agreement With Clinical Care Options as Its Authorized Online Conference Coverage Provider for the Liver Meeting(R) 2008
Post Your Comments:
*Name:
*Comment:
*Email: